|
|
|
Estrofem
Product: Estrofem
Drug Name: Estrogen
Packaging Type: Packets of 28 x 1mg & 28 x 2mg tablets
Manufacturer: Novo Nordisk
| Estrofem 1mg Tablets Prices |
| 1 packet (28 tablets) of Estrofem 1mg |
US$12.00 |
 |
| 2 packets (56 tablets) of Estrofem 1mg |
US$23.00 |
|
| 3 packets (84 tablets) of Estrofem 1mg |
US$33.00 |
|
| Estrofem 2mg Tablets Prices |
| 1 packet (28 tablets) of Estrofem 2mg |
US$18.00 |
|
| 2 packets (56 tablets) of Estrofem 2mg |
US$35.00 |
|
| 3 packets (84 tablets) of Estrofem 2mg |
US$51.00 |
|
What is Estrofem used for?
Estrofem may be used as a supplement to, or substitution for, the ovaries' endogenous estrogen production. Estrofem causes a decrease in or complete disappearance of estrogen deficiency symptoms.
How to take EstrofemOral estrogen usually is taken by mouth either every day or on a cyclical basis: once a day for 21 days and then none for 7 days; then the cycle is repeated. However, for treating cancer it usually is taken three times a day, every day for at least 3 months.
Side effects of Estrofem
During the first few months of treatment with Estrofem breast tenderness may occur. Nausea, headache, and oedema occur rarely. Symptoms are normally transient. Further more, skin reactions have been reported.
Precautions when taking Estrofem
Physical examination and a complete medical and family history should be taken prior to the initiation of any estrogen therapy with special reference to blood pressure, palpation of the breasts and the abdomen, and a gynecological examination. Patients with intact uterus who are or have previously been treated with unopposed estrogens should be examined with special care in order to investigate a possible hyperstimilation of the endometrium before commencing Estrofem therapy. As a general rule, estrogens should not be prescribed for longer than one year without another physical examination including gynecological examination being performed. If abnormal or irregular bleeding occurs during or shortly after therapy diagnostic aspiration biopsy or curettage should be performed to rule out the possibility of uterine malignancy. As a general rule for hormone replacement therapy (HRT) the lowest dose which alleviates the symptoms should be prescribed and medication should be discontinued as soon as possible. In patients treated with antihypertensive drugs and hormone replacement therapy (HRT) blood pressure should be monitored regularly. Patients with epilepsy, migraine, diabetes, asthma or cardiac failure should be carefully controlled as estrogens may worsen these conditions. Thromboembolism has been reported in connection with estrogen replacement therapy but there is no background to believe that the overall incidence is increased. The indications for immediate withdrawal of therapy are: Deep venous thrombosis, thromboembolic disorders, the emergence of migraine-type headaches, sudden visual disturbances, significant increase in blood pressure. It is also advisable to withdraw treatment 4 to 6 weeks before major surgery. Estrofem has no contraceptive effects.
|
|
|
|
